Vasoplegic syndrome in cardiac surgery: role of synergism between polymorphism of tumor necrosis factor beta and plasminogen activator inhibitor type 1

Documenti analoghi

• Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
  di: Jimenez, J, et al.
  Pubblicazione: (2007)
• Interaction between etomidate and beta tumoral necrosis factor on hemodynamic response after cardiac surgery
  di: Iribarren, JL, et al.
  Pubblicazione: (2015)
• Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
  di: Brouard, M, et al.
  Pubblicazione: (2008)
• Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
  di: Iribarren, J, et al.
  Pubblicazione: (2007)
• Global longitudinal strain value for predicting left ventricular remodeling after primary percutaneous reperfusion therapy in acute myocardial infarction
  di: Jiménez, JJ, et al.
  Pubblicazione: (2015)